Therapeutic Effects of GLP-1 Analog on Rats with Experimental Diabetes Mellitus

ZHAO Hai-jun,XU Qi,ZHANG Gui-ying,LIU Ya,YU Ting,LI Hong-yan,YANG Li-na,WANG Hong-ying,XIE Li-bo
DOI: https://doi.org/10.3969/j.issn.1671-587x.2007.03.017
2007-01-01
Abstract:Objective To investigate the therapeutic effects of glucagon-like peptide-1(GLP-1) analog on rats with experimental diabetes mellitus.Methods Eighty-four Wistar rats were divided randomly into normal control group,high fat forage group,low-dose GLP-1 analog group,middle-dose GLP-1 analog group,highdose GLP-1 analog group,diabetes mellitus model group and positive control group.Diabetes mellitus animal models were induced with high fat forage and injection of 40 mg·kg-1 STZ.After 7 and 14 d of GLP-1 analog therapy,the level of fasting plasma glucose(FPG) was detected with enzyme-chemical method.After 14 d of GLP1 analog therapy,the levels of serum total cholesterols(TC),triglyceride(TG),low-density lipoprotein(LDL) and high-density lipoprotein(HDL) were detected with enzyme-chemical method.The levels of serum insulin and C-peptide were measured with immunoradiometric assay method.Results After 14 d of GLP-1 analog injection,food intake in high-dose GLP-1 analog(100 μg·kg-1)group was less than that in DM group(P0.01);Water intake in middle-dose GLP-1 analog(10 μg·kg-1) group and high dose(100 μg·kg-1)group were less than that in DM group(P0.01).There were no statistical differences of body weight between all therapeutic groups and DM group(P0.05).The levels of FPG in middle-dose GLP-1 analog(10 μg·kg-1 ) group and high dose(100 μg·kg-1)group were lower than that in DM group(P0.01).The level of TG in high-dose GLP-1 analog(100 μg·kg-1)group was lower than that in DM group(P0.01).The levels of LDL in middle-dose GLP1 analog(10 μg·kg-1) group and high dose(100 μg·kg-1)group were lower than that in DM group(P0.01).The levels of serum insulin and C-peptide in middle-dose GLP-1 analog(10 μg·kg-1) group and high dose(100 μg·kg-1)group were higher than that in DM group(P0.05).Conclusion GLP-1 analog can paly an important role in treatment of experimental diabetes mellitus through multiple ways.
What problem does this paper attempt to address?